A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

Clinical trial NCT06248229 · RECRUITING

Trial details

NCT number: NCT06248229
Sponsor: Rochester Center for Behavioral Medicine
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Fatigue Attention Deficit Hyperactivity Disorder Attention Deficit Disorder

Start date: 2024-09-01
Primary completion: 2026-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.